期刊
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
卷 445, 期 1, 页码 230-235出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2014.01.182
关键词
DNA methylation; Epigenetics; Histone acetylation; Secreted phospholipase A(2); Lipid signalling; Breast cancer
资金
- Slovenian Research Agency [P1-0207]
- French-Slovene partnership project [BI-FR/12-13-PROTEUS-006]
- CNRS
- Association for International Cancer Research
- Fondation ARC pour la recherche sur le cancer
Secreted phospholipases A(2) (sPLA(2)s) have recently been associated with several cancers, but their role in breast cancer is unknown. Here we demonstrate that mRNA expression of group IIA, III and X sPLA(2)s differs both in vivo in tumour biopsies and in breast cancer cells in vitro. Their expression is differentially regulated by DNA methylation and histone acetylation and, significantly, all three genes are silenced in aggressive triple negative cells due to both mechanisms. The transcription start site promoter region and the upstream CpG islands, exclusive to the group X sPLA(2) gene, have variable roles in the regulation of sPLA(2) expression. Our results suggest that the differential expression of hGIIA, hGIII and hGX sPLA(2)s in breast cancer cells is a consequence of various degrees of epigenetic silencing due to DNA hypermethylation and histone deacetylation. (C) 2014 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据